Health Care-Associated Infections

According to the US Department of Health and Human Services, 1 in 25 hospital patients has a health care – associated infection at any given time, and these infections are responsible for the loss of tens of thousands of lives and billions of dollars in preventable health care costs each year.

Despite sanitation protocols and the implementation of comprehensive aseptic technique by healthcare professionals, which include Hand Hygieneing, gloving, aprons, surface sanitation, isolation and rigorous quality controls, patients are not entirely isolated from pathogens. Once a patient develops an infection, even the best treatments currently available are becoming less effective. Antibiotic use has also now become a public health issue as bacterial drug resistance has been confirmed across all classes of pathogens.

Zurex Pharma plans to complete the development and commercialization of novel, proprietary products designed to prevent or minimize HAI and targeted for several distinct critical care areas:

  • Surgical site infections (SSI)
  • Patient Bathing & Patient Prep
  • Wound care
  • Catheter-related bloodstream infections (CRBSI) in central line catheters


Zurex Pharma's corporate office is located in the Middleton Industrial Park. Specific comments or questions may be submitted online through our contact page.


Presurgical skin preparation
for the prevention of surgical
site infections.

Patient Bathing

Novel, highly effective, anti-septic patient bathing and hand hygiene products are in the works.

Wound Care

Post-surgical solutions for the prevention of surgical site infections and wound management.


Prevention of intra-luminal catheter-related bloodstream infections in central line catheters.

Zurex Product Line

Our goal is to provide safe and effective anti-microbial products designed to reduce the risks associated with health care-associated infections with a focus on surgical site wounds and catheter-related bloodstream infections (CRBSI).